№2 / 2018

  1. THE SAMPLE SIZE OF LABORATORY ANIMALS FOR EXPERIMENTAL STUDIES
    Makarova M.N., Shekunova E.V., Rybakova A.V., Makarov V.G.
  2. YELLOW IRIS (IRIS PSEUDACORUS L.): CHEMICAL COMPOSITION AND PHARMACOLOGICAL EFFECTS
    Tikhomirova E.A., Sorokina A.A.
  3. CATALYTIC SYNTHESIS OF AMINO COMPOUNDS, INTERMEDIATES FOR THE SYNTHESIS OF PHARMACEUTICAL SUBSTANCES
    Kuzmicheva E.L., Pyatigorskaya N.V., Sapozhnikova E.A.
  4. SEA BUCKTHORN (HIPPOHAE RHAMNOIDES) BERRIES: THE MORPHOLOGICAL AND ANATOMICAL SIGNS OF DIFFERENT VARIETIES
    Rudaya M.A., Trineeva O.V., Gudkova A.A., Slivkin A.I., Boiko G.A., Danshina I.A.
  5. IMPACT OF GRINDING GRADE ON TANNIN CONTENTS IN MEDICINAL PLANT PREPARATIONS AND MEDICINAL RAW MATERIALS
    Kalinin A.M., Antonova N.P., Prokhvatilova S.S., Shefer E.P., Morgunov I.M.
  6. INVESTIGATION OF THE MORPHOLOGICAL AND ANATOMICAL STRUCTURE OF HAWKWEED OXTONGUE (PICRIS HIERACIOIDES)
    Bubenchikova V.N., Kondratova Yu.A., Stepnova I.V
  7. DETERMINATION OF THE OPTIMAL COMPOSITION OF POWDER INHALATION FORMULATION
    Ivanov V.A., Sorokin V.V., Markova A.V.
  8. ASSESSMENT OF PHARMACOECONOMIC APPROACHES TO MANAGING THE QUALITY OF DRUG PROVISION IN HEALTH CARE FACILITIES
    Vaskova L.B., Maksimkina E.A., Romantseva N.V., Dukhovich V.P.
  9. DEVELOPMENT STRATEGY FOR THE BUSINESS POTENTIAL OF PHARMACY NETWORKS WITH CONSIDERATION FOR BALANCED INDICATORS
    Razdorskaya I.M., Zanina I.A., Plokhikh I.V.
  10. THE DRUG PROVISION SYSTEM FOR PATIENTS WITH ORPHAN DISEASES IN THE SUBJECTS OF THE SOUTHERN FEDERAL DISTRICT: OPPORTUNITIES AND THREATS
    Kosyakova N.V.